van Hoek AJ - Search Results

1

The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England.

van Hoek AJ, Choi YH, Trotter C, Miller E, Jit M. van Hoek AJ, et al. Vaccine. 2012 Nov 26;30(50):7205-13. doi: 10.1016/j.vaccine.2012.10.017. Epub 2012 Oct 23. Vaccine. 2012. PMID: 23084850

2

Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines.

Rozenbaum MH, Sanders EA, van Hoek AJ, Jansen AG, van der Ende A, van den Dobbelsteen G, Rodenburg GD, Hak E, Postma MJ. Rozenbaum MH, et al. Among authors: van hoek aj, van der ende a, van den dobbelsteen g. BMJ. 2010 Jun 2;340:c2509. doi: 10.1136/bmj.c2509. BMJ. 2010. PMID: 20519267

3

Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.

van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N. van Hoek AJ, et al. Vaccine. 2011 Mar 16;29(13):2411-20. doi: 10.1016/j.vaccine.2011.01.037. Epub 2011 Jan 28. Vaccine. 2011. PMID: 21277405

4

The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study.

van Hoek AJ, Underwood A, Jit M, Miller E, Edmunds WJ. van Hoek AJ, et al. PLoS One. 2011 Mar 2;6(3):e17030. doi: 10.1371/journal.pone.0017030. PLoS One. 2011. PMID: 21399678 Free PMC article.

5

Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.

Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N, Sheppard C, George R, Miller E. Flasche S, et al. Among authors: van hoek aj. PLoS Med. 2011 Apr;8(4):e1001017. doi: 10.1371/journal.pmed.1001017. Epub 2011 Apr 5. PLoS Med. 2011. PMID: 21483718 Free PMC article.

6

The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.

van Hoek AJ, Melegaro A, Gay N, Bilcke J, Edmunds WJ. van Hoek AJ, et al. Vaccine. 2012 Feb 1;30(6):1225-34. doi: 10.1016/j.vaccine.2011.11.026. Epub 2011 Nov 23. Vaccine. 2012. PMID: 22119592

7

The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England.

van Hoek AJ, Andrews N, Waight PA, Stowe J, Gates P, George R, Miller E. van Hoek AJ, et al. J Infect. 2012 Jul;65(1):17-24. doi: 10.1016/j.jinf.2012.02.017. Epub 2012 Mar 3. J Infect. 2012. PMID: 22394683

8

Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes.

van Hoek AJ, Andrews N, Waight PA, George R, Miller E. van Hoek AJ, et al. PLoS One. 2012;7(7):e39150. doi: 10.1371/journal.pone.0039150. Epub 2012 Jul 16. PLoS One. 2012. PMID: 22815698 Free PMC article.

9

Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis.

Rozenbaum MH, van Hoek AJ, Fleming D, Trotter CL, Miller E, Edmunds WJ. Rozenbaum MH, et al. Among authors: van hoek aj. BMJ. 2012 Oct 26;345:e6879. doi: 10.1136/bmj.e6879. BMJ. 2012. PMID: 23103369 Free PMC article.

10

A cost effectiveness and capacity analysis for the introduction of universal rotavirus vaccination in Kenya: comparison between Rotarix and RotaTeq vaccines.

van Hoek AJ, Ngama M, Ismail A, Chuma J, Cheburet S, Mutonga D, Kamau T, Nokes DJ. van Hoek AJ, et al. PLoS One. 2012;7(10):e47511. doi: 10.1371/journal.pone.0047511. Epub 2012 Oct 24. PLoS One. 2012. PMID: 23115650 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters